{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:45:14Z","timestamp":1788878714295,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.anpede.2025.503815","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T15:17:51Z","timestamp":1752851871000},"page":"503815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Recommendations for the safe use of high-risk medications in pediatrics"],"prefix":"10.1016","volume":"103","author":[{"given":"Mar\u00eda Jos\u00e9","family":"Otero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n Rodr\u00edguez","family":"Marrodan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria Prieto","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique Villalobos","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Manrique","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca Padilla","family":"Peinado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia M.","family":"Fern\u00e1ndez-Llamazares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora Madrid","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpede.2025.503815_bib0005","series-title":"Medication without harm. Policy brief","year":"2023"},{"key":"10.1016\/j.anpede.2025.503815_bib0010","series-title":"Plan de acci\u00f3n mundial para la seguridad del paciente 2021-2030: hacia la eliminaci\u00f3n de los da\u00f1os evitables en la atenci\u00f3n de salud","year":"2021"},{"key":"10.1016\/j.anpede.2025.503815_bib0015","series-title":"Medication safety in high-risk situations","year":"2019"},{"key":"10.1016\/j.anpede.2025.503815_bib0020","series-title":"Medication Errors","first-page":"317","article-title":"High-alert medications: safeguarding against errors","author":"Cohen","year":"2007"},{"issue":"16","key":"10.1016\/j.anpede.2025.503815_bib0025","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.285.16.2114","article-title":"Medication errors and adverse drug events in pediatric inpatients","volume":"285","author":"Kaushal","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.anpede.2025.503815_bib0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/qshc.2006.019950","article-title":"Medication errors in paediatric care: a systematic review of epidemiology and an evaluation of evidence supporting reduction strategy recommendations","volume":"16","author":"Miller","year":"2007","journal-title":"Qual Saf Health Care."},{"key":"10.1016\/j.anpede.2025.503815_bib0035","unstructured":"Estrategia de Seguridad del Paciente del Sistema Nacional de Salud. Periodo 2015- 2020. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2015. [Accessed 20 January 2025]. Available from: https:\/\/seguridaddelpaciente.sanidad.gob.es\/docs\/Estrategia_Seguridad_del_Paciente_2015-2020.pdf."},{"key":"10.1016\/j.anpede.2025.503815_bib0040","unstructured":"Recomendaciones para el Uso Seguro de los Medicamentos de Alto Riesgo. Madrid: Ministerio de Sanidad, Instituto para el Uso Seguro de los Medicamentos; 2023 [Accessed 20 January 2025]. Available from: https:\/\/seguridaddelpaciente.sanidad.gob.es\/practicasSeguras\/usoSeguroMedicamentos\/docs\/Recomendaciones__para_el_Uso_Seguro_Medicamentos_Alto_Riesgo-_2023.pdf."},{"key":"10.1016\/j.anpede.2025.503815_bib0045","unstructured":"Recomendaciones para el Uso Seguro de los Medicamentos de Alto Riesgo en Pediatr\u00eda. Madrid: Ministerio de Sanidad, Instituto para el Uso Seguro de los Medicamentos, Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda y Sociedad Espa\u00f1ola de Farmacia Hospitalaria; 2024. [Accessed 20 May 2025]. Available from: https:\/\/seguridaddelpaciente.sanidad.gob.es\/practicasSeguras\/usoSeguroMedicamentos\/docs\/Recomendaciones_Uso_Seguro_Medicamentos_Alto_Riesgo_Pediatria.ACCESIBLE.pdf"},{"issue":"6","key":"10.1016\/j.anpede.2025.503815_bib0050","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1517\/14740338.2013.825247","article-title":"High-alert medications for pediatric patients: an international modified Delphi study","volume":"12","author":"Maaskant","year":"2013","journal-title":"Expert Opin Drug Saf."},{"issue":"12","key":"10.1016\/j.anpede.2025.503815_bib0055","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1111\/apa.15273","article-title":"Cross-sectional study identifying high- alert substances in medication error reporting among Swedish paediatric inpatients","volume":"109","author":"Nydert","year":"2020","journal-title":"Acta Paediatr."},{"issue":"1","key":"10.1016\/j.anpede.2025.503815_bib0060","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/PCC.0b013e3181936ff8","article-title":"High-alert medications in the pediatric intensive care unit","volume":"10","author":"Franke","year":"2009","journal-title":"Pediatr Crit Care Med."},{"issue":"6","key":"10.1016\/j.anpede.2025.503815_bib0065","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.anpedi.2013.04.026","article-title":"Lista modelo de medicamentos de alto riesgo","volume":"79","author":"Cotrina Luque","year":"2013","journal-title":"An Pediatr (Barc)."},{"issue":"2","key":"10.1016\/j.anpede.2025.503815_bib0070","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/jep.12302","article-title":"High-alert medications in a French paediatric university hospital","volume":"21","author":"Bataille","year":"2015","journal-title":"J Eval Clin Pract."},{"issue":"6","key":"10.1016\/j.anpede.2025.503815_bib0075","first-page":"207","article-title":"High-alert medications for hospitalised paediatric patients - a two-step survey among paediatric clinical expert pharmacists in Germany","volume":"77","author":"Schilling","year":"2022","journal-title":"Pharmazie."},{"issue":"7","key":"10.1016\/j.anpede.2025.503815_bib0080","first-page":"1","article-title":"Your high-alert medication list- Relatively useless without associated risk-reduction strategies","volume":"18","year":"2013","journal-title":"ISMP Medication Safety Alert"},{"issue":"19","key":"10.1016\/j.anpede.2025.503815_bib0085","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2146\/ajhp170811","article-title":"ASHP guidelines on preventing medication errors in hospitals","volume":"75","author":"Billstein-Leber","year":"2018","journal-title":"Am J Health Syst Pharm."},{"key":"10.1016\/j.anpede.2025.503815_bib0090","unstructured":"Health Information and Quality Authority. Guide to HIQA\u2019s medication safety monitoring programme against the National Standards for Safer, Better Healthcare in acute healthcare services in 2019. [Accessed 20 January 2025]. Available from: https:\/\/www.hiqa.ie\/sites\/default\/files\/2019-01\/Medication_Safety_Monitoring_Programme_Guide_2019.pdf."},{"key":"10.1016\/j.anpede.2025.503815_bib0095","series-title":"Department of Health. Health high risk medication policy","year":"2020"},{"key":"10.1016\/j.anpede.2025.503815_bib0100","series-title":"Joint Commission International Accreditation Standards for Hospitals","year":"2023"},{"key":"10.1016\/j.anpede.2025.503815_bib0105","unstructured":"ISMP Canada. Canadian High-Alert Medication List. User Guide 2024 Edition. [Accessed 20 January 2025]. Available from: https:\/\/ismpcanada.ca\/wp-content\/uploads\/ISMP-Canada-High-Alert-Med-List-User-Guide-2024.pdf."},{"key":"10.1016\/j.anpede.2025.503815_bib0110","series-title":"Clinical Excellence Commission. High-risk medicines management","year":"2024"},{"key":"10.1016\/j.anpede.2025.503815_bib0115","series-title":"Office of Disease Prevention and Health Promotion. National Action Plan for Adverse Drug Event Prevention","year":"2014"},{"key":"10.1016\/j.anpede.2025.503815_bib0120","series-title":"The National guidelines on high alert medications","year":"2021"},{"key":"10.1016\/j.anpede.2025.503815_bib0125","series-title":"ISMP Targeted medication safety best practices for hospitals","year":"2024"},{"key":"10.1016\/j.anpede.2025.503815_bib0130","first-page":"1","article-title":"Designing effective recommendations","volume":"4","year":"2013","journal-title":"Ontario Crit Incident Learning"},{"issue":"11","key":"10.1016\/j.anpede.2025.503815_bib0135","first-page":"1","article-title":"Education is \u201cpredictably disappointing\u201d and should never be relied upon alone to improve safety","volume":"25","year":"2020","journal-title":"ISMP Med Saf Alert"},{"issue":"4 Pt 1","key":"10.1016\/j.anpede.2025.503815_bib0140","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.111.4.722","article-title":"Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients","volume":"111","author":"Fortescue","year":"2003","journal-title":"Pediatrics."},{"issue":"3","key":"10.1016\/j.anpede.2025.503815_bib0145","doi-asserted-by":"crossref","first-page":"e421","DOI":"10.1542\/peds.2007-0220","article-title":"Effect of computer order entry on prevention of serious medication errors in hospitalized children","volume":"121","author":"Walsh","year":"2008","journal-title":"Pediatrics."},{"issue":"6","key":"10.1016\/j.anpede.2025.503815_bib0150","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/archdischild-2011-301239","article-title":"Impact of clinical pharmacist interventions in reducing paediatric prescribing errors","volume":"97","author":"Fern\u00e1ndez-Llamazares","year":"2012","journal-title":"Arch Dis Child."},{"key":"10.1016\/j.anpede.2025.503815_bib0155","first-page":"96","article-title":"Medication errors affecting pediatric patients: Unique challenges for this special population","volume":"12","year":"2015","journal-title":"Pa Patient Saf Advis"},{"issue":"7","key":"10.1016\/j.anpede.2025.503815_bib0160","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.medin.2016.01.011","article-title":"Safe intravenous administration in pediatrics: A 5-year pediatric intensive care unit experience with smart pumps","volume":"40","author":"Manrique-Rodr\u00edguez","year":"2016","journal-title":"Med Intensiva."},{"key":"10.1016\/j.anpede.2025.503815_bib0165","series-title":"ISMP Medication Safety Self Assessment\u00a9 for high-alert medications","year":"2017"},{"key":"10.1016\/j.anpede.2025.503815_bib0170","series-title":"Cuestionario de autoevaluaci\u00f3n de la seguridad del sistema de utilizaci\u00f3n de los medicamentos en los hospitales","year":"2018"},{"issue":"10","key":"10.1016\/j.anpede.2025.503815_bib0175","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/jphp.12992","article-title":"A national scoping survey of standard infusions in paediatric and neonatal intensive care units in the United Kingdom","volume":"70","author":"Oskarsdottir","year":"2018","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"10.1016\/j.anpede.2025.503815_bib0180","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/s-0040-1709508","article-title":"The impact of technology on prescribing errors in pediatric intensive care: A before and after study","volume":"11","author":"Howlett","year":"2020","journal-title":"Appl Clin Inform"},{"issue":"11","key":"10.1016\/j.anpede.2025.503815_bib0185","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1080\/17425247.2023.2273838","article-title":"Small patients, big challenges: navigating pediatric drug manipulations to prevent medication errors- a comprehensive review","volume":"20","author":"Chachlioutaki","year":"2023","journal-title":"Expert Opin Drug Deliv."},{"issue":"1","key":"10.1016\/j.anpede.2025.503815_bib0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11096-023-01652-3","article-title":"Implementation of a national system for best practice delivery of paediatric infusions","volume":"46","author":"Howlett","year":"2024","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"10.1016\/j.anpede.2025.503815_bib0195","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/ejhpharm-2022-003316","article-title":"Standardisation of intravenous infusion therapy for paediatrics: big challenges for the little patients","volume":"31","author":"Taladriz-Sender","year":"2024","journal-title":"Eur J Hosp Pharm."},{"key":"10.1016\/j.anpede.2025.503815_bib0200","series-title":"Cinco momentos clave para la utilizaci\u00f3n segura de los medicamentos. Gu\u00eda para los profesionales sanitarios","year":"2022"}],"container-title":["Anales de Pediatr\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287925000596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287925000596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:32:24Z","timestamp":1760214744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2341287925000596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2341287925000596"],"URL":"https:\/\/doi.org\/10.1016\/j.anpede.2025.503815","relation":{},"ISSN":["2341-2879"],"issn-type":[{"value":"2341-2879","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for the safe use of high-risk medications in pediatrics","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpede.2025.503815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2025.503815","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Espa\u00f1a S.L.U. on behalf of Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda and Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H).","name":"copyright","label":"Copyright"}],"article-number":"503815"}}